 | | Tenofovir (Viread) |  | | Published
October 02, 2001; Updated
February 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-01-07 | | | Selected References | | 17. | McComsey GA, Kitch D, Daar ES, et al. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis. 2011 Jun 15;203(12):1791-801. | |
| 28. | Grant RM, Lama JR, Anderson PL, et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587-99. | |
|
|
|
